Agopyan Nadia 4
4 · Marker Therapeutics, Inc. · Filed Aug 19, 2019
Insider Transaction Report
Form 4
Agopyan Nadia
VP, Regulatory Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2019-08-15+200,000→ 200,000 totalExercise: $4.80Exp: 2029-08-15→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares underlying the Option shall vest on August 15, 2020, with the balance of the shares vesting in thirty-six (36) equal monthly installments thereafter.